Drugs / Dendritic cell based cryoimmunotherapy
Dendritic cell based cryoimmunotherapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02423928 | May 2015 → Aug 2019 | prostate cancer | Alden Cancer Therapy II | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic cell based cryoimmunotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02423928 ↗ |
| Modality | Cell therapy | “Autologous dendritic cells will be obtained following leukapheresis and cytokine induction and will be injected into cryoablated prostate cancer tissue under ultrasound guidance.” NCT02423928 ↗ |
| Route | Other | “will be injected into cryoablated prostate cancer tissue” NCT02423928 ↗ |